In conclusion, by combining phage display, cellular panning and NGS analyses of an immune library, we successfully identified two novel CD38 and ICAM-1 antibodies, and at least 7 antibodies targeting yet unknown, potentially novel antigens on myeloma cell surface. Here, ICAM1 is linked to plasma cell myeloma.